Transplt allo hct/donor
38240 reports allogeneic hematopoietic cell transplantation. Choose 38243 for a subsequent hematopoietic cell boost after a prior transplant.
CMS RVU26D · Effective 2026-10-01
Reports infusion of hematopoietic progenitor cells as a boost after failed engraftment, hematologic relapse, or graft rejection following an earlier transplant. Compare 38243 office and facility rates across CMS payment localities in Wyoming.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
Wyoming has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
No supported rate
$100.32
1 of 1 localities have a supported rate.
Payment area: Wyoming**
One mapped payment locality.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Hematopoietic transplantation
Reports infusion of hematopoietic progenitor cells as a boost after failed engraftment, hematologic relapse, or graft rejection following an earlier transplant.
A hematopoietic progenitor cell boost delivers additional blood-forming cells after an earlier transplant when engraftment has failed, the disease has relapsed hematologically, or the graft has been rejected. The transplant physician or hematologist typically performs the infusion in a hospital setting. This service is distinct from the original allogeneic or autologous transplant and from an infusion of donor lymphocytes, which is not a hematopoietic cell boost.
Report 38243 for the boost itself, supported by documentation of the prior transplant, the clinical indication, and the infused hematopoietic cell product. The code has a 0-day global period, so same-day preoperative and postoperative care is included. When multiple procedures occur in the same session, the highest-valued procedure is paid in full and other procedures are subject to the standard 50% reduction. Bilateral adjustment does not apply. Assistant-at-surgery payment requires documented medical necessity; co-surgeons and team surgery are not permitted.
46
Medicare services in 2024 · #5403 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Office rates for Wyoming, from the same CMS release.
Transplt allo hct/donor
38240 reports allogeneic hematopoietic cell transplantation. Choose 38243 for a subsequent hematopoietic cell boost after a prior transplant.
Transplt autol hct/donor
38241 reports autologous hematopoietic cell transplantation. It is not the code for a later boost following an earlier transplant.
38242 reports infusion of donor lymphocytes. Use 38243 when the infused product is a hematopoietic progenitor cell boost.
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Office / nonfacility
Unavailable
Facility
$100.32
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for 38243 in Wyoming**.
PPRRVU2026_Oct_nonQPP.csv
4,734
GPCI2026.csv
112
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 2.08 | × 1.000 | 2.0800 |
| Practice expense | 0.82 | × 1.000 | 0.8200 |
| Malpractice | 0.14 | × 0.740 | 0.1036 |
| Total RVUs | 3.0036 | ||
| Conversion factor | × 33.4009 | ||
Facility rate, Wyoming**$100.32
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 2.08 | 1 |
| Practice expense | 0.82 | 1 |
| Malpractice | 0.14 | 0.74 |
(2.08 × 1 + 0.82 × 1 + 0.14 × 0.74) × $33.4009 = $100.32
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
Use 38243 for an additional hematopoietic cell infusion after a prior transplant in the setting of failed engraftment, hematologic relapse, or graft rejection. Codes 38240 and 38241 describe allogeneic and autologous transplantation, respectively.
38243 is for a hematopoietic progenitor cell boost. An infusion of donor lymphocytes is a different service reported with 38242.
The service is the boost infusion, not the harvest or laboratory manipulation of cells. Review separately performed collection or processing against the applicable code instructions and documentation.
Document the previous transplant, the reason for the boost, and the hematopoietic cell product infused. The record should distinguish the boost from an initial transplant or donor lymphocyte infusion.
Assistant-at-surgery payment is allowed only when medical necessity is documented. Co-surgeons and team surgery are not permitted for this code.
When it is performed in the same session with other procedures, the highest-valued procedure is paid in full and the others are subject to the standard 50% reduction. The 0-day global period includes same-day preoperative and postoperative care.
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.